Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?
about
Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null miceHeptanoate as a neural fuel: energetic and neurotransmitter precursors in normal and glucose transporter I-deficient (G1D) brainMechanisms of Action of Antiseizure Drugs and the Ketogenic DietTriheptanoin improves brain energy metabolism in patients with Huntington diseaseGlucose and Intermediary Metabolism and Astrocyte-Neuron Interactions Following Neonatal Hypoxia-Ischemia in Rat.Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life.Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral SclerosisCutaneous Adverse Drug Reactions in Dogs Treated with Antiepileptic DrugsBrain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in miceGlutamate synthesis has to be matched by its degradation - where do all the carbons go?Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine.The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.Hepatic Ketogenesis Induced by Middle Cerebral Artery Occlusion in Mice.Short- and medium-chain fatty acids in energy metabolism: the cellular perspective.Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy.Lipid profiling of cyanobacteria Synechococcus sp. PCC 7002 using two-dimensional liquid chromatography with quadrupole time-of-flight mass spectrometry.Anaplerosis for Glutamate Synthesis in the Neonate and in Adulthood.Effects of ketogenic diets on the occurrence of pilocarpine-induced status epilepticus of rats.Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43.Metabolic perturbations associated with the consumption of a ketogenic medium-chain TAG diet in dogs with idiopathic epilepsy
P2860
Q21131923-B89EBA4A-45F4-4FA5-A200-F58A5361F3AFQ22337252-D7B98B2D-6B09-4BC3-8AFC-64D52BED8771Q28272457-2A570A1F-0EC6-46D0-A8D7-7EF7638515B3Q28388261-B3AF3AF1-896E-46DC-BD40-952E1C653428Q31151332-3196F3B0-60BD-46E5-949C-3CA4EA93A46DQ33858770-59D6FB9B-A104-41B5-9FEE-0D4D9451BF26Q36114275-B90B65AA-E5C1-4AF0-8D05-602FA9FB276CQ36795791-B40989F3-A1E5-467C-A500-0581978E3011Q36994337-9330B8D4-8C04-4D23-9110-90A3FCF0AFE7Q38225717-56191EBD-32C6-4CD5-B092-58C41ADD5B67Q38598388-EA210999-EEEB-48E0-8A11-228E34DCA125Q38809233-5ED864C6-9534-4D33-8799-E151433DA880Q38851664-9253E3B4-2B3A-4B10-84AD-319A22B4C4A1Q42766173-4B83EF78-4C44-4232-852A-C59186E1451FQ45181504-E1F5D3C6-CC50-4D12-A5F0-085EE634D7EAQ46503631-2DBEFADE-5A30-45CD-BD9C-5180BAFDD947Q48417498-A8E2A8DB-BF3A-403F-B393-73B984360239Q48669698-CFB28375-D5B7-40CD-A291-343646995276Q55237897-14DD2CA9-AD32-46BF-86F3-C6FB438830ADQ57162761-50E3785A-6BF9-4A75-AD78-F177B0FCDE60
P2860
Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Triheptanoin--a medium chain t ...... otic anticonvulsant treatment?
@en
Triheptanoin--a medium chain t ...... otic anticonvulsant treatment?
@nl
type
label
Triheptanoin--a medium chain t ...... otic anticonvulsant treatment?
@en
Triheptanoin--a medium chain t ...... otic anticonvulsant treatment?
@nl
prefLabel
Triheptanoin--a medium chain t ...... otic anticonvulsant treatment?
@en
Triheptanoin--a medium chain t ...... otic anticonvulsant treatment?
@nl
P2860
P1433
P1476
Triheptanoin--a medium chain t ...... otic anticonvulsant treatment?
@en
P2093
Ursula Sonnewald
P2860
P304
P356
10.1016/J.EPLEPSYRES.2011.05.023
P50
P577
2011-08-19T00:00:00Z